The leucine analogue 5',5',5', -trifluoroleucine (fluoroleucine) replaced leucine for repression of the isoleucine-valine biosynthetic enzymes in Salmonella typhimurium. In contrast, the analogue had no effect on derepression of the leucine biosynthetic enzymes in leucine auxotrophs grown on limiting amounts of leucine. The effect of fluoroleucine on repression appeared to be specific for leucine since derepression of the icoleucine-valine enzymes due to an isoleucine or valine limitation was not affected by the analogue. The prevention of derepression by fluoroleucine was probably due to repression and not to the formation of false proteins, since the analogue had no effect on the derepression of a number of enzymes unrelated to the isoleucine-valine pathway. Fluoroleucine was able to attach to leucine transfer ribonucleic acid (tRNA) as evidenced by the ability of the analogue to protect about 70% of leucine tRNA from oxidation by periodate. We propose that the differential effects of fluoroleucine on repression are due to differences in the ability of the analogue to bind to the various species of leucine tRNA.
The formation of the enzymes leading to isoleucine and valine synthesis in Salmonella typhimurium and Escherichia coli is controlled by multivalent repression (8) . In this process, isoleucine, valine, leucine, and pantothenic acid are required for repression of the isoleucine-valine biosynthetic enzymes. The formation of the enzymes involved in leucine biosynthesis is regulated only by leucine (3, 8) . It has recently been shown that the activation of leucine by leucyl transfer ribonucleic acid (tRNA) synthetase is required for leucine to participate in repression of the isoleucine-valine and leucine enzymes (Alexander, Freundlich, and Calvo, in preparation). This conclusion was based on the properties of mutants of S. typhimurium that were derepressed for the isoleucine-valine and leucine enzymes (5) . The mutants were isolated by virtue of their resistance to the specific leucine antagonist 5', 5', 5'-trifluoro-DL-leucine (fluoroleucine). This analogue has been shown, under certain conditions, to be incorporated into protein in place of leucine (15) . In a number of systems, a close correlation has been found between the capacity of an analogue to be incorporated into protein and the ability of ' Presented in part at the 68th Annual Meeting of the American Society for Microbiology, Detroit, Mich., 5-10 May 1968. the analogue to act as a co-repressor (7, 11, 12) . This communication describes, in S. typhimurium, the ability of fluoroleucine to replace leucine as a co-repressor for the isoleucine-valine biosynthetic enzymes but not for the leucine enzymes.
MATERIALS AND METHODS
Bacterial strains. All of the strains used in this report were derived from S. typhimurium strain LT2 ara-9. Most of the strains employed were obtained from the collection of P. Margolin.
Media and growth conditions. Except where otherwise noted, the bacteria were grown overnight at 37 C in 200 ml of a 0.2% glucose-minimal medium (6) contained in 1-liter Erlenmeyer flasks. The cultures were agitated in a New Brunswick incubator-gyratory shaker and harvested during late exponential or early stationary growth. The inoculum was 0.2 ml of an overnight culture grown in 1% Nutrient Broth (Difco). Growth was measured in a Klett-Summerson colorimeter with a blue no. 42 filter.
Enzyme methods. The procedure for the preparation of crude extracts and protein determination was the same as described previously (19) (13) . The fraction of leucine tRNA that is charged was determined by oxidation with NaIO4 (2) except that the washing of the trichloroacetic acid-precipitated samples and the radioactivity determinations were done as described previously (7).
Chemicals. All of the chemicals used were obtained from Sigma Chemical Co., St. Louis, Mo., except the following: a-acetohydroxybutyrate, a,#B-dihydroxyisovaleric acid, and fluoroleucine were gifts from H. E. Umbarger; ,B-isopropylmalic acid was a gift from J. Calvo; L-leucine-1-41C was obtained from New England Nuclear Corp., Boston, Mass.
RESULTS
Effect of fluoroleucine on repression of the isoleucine-valine and leucine enzymes. When S. typhimurium strain leu-130 ilv-224 was grown in ninimal medium with growth-limiting amounts of leucine, the isoleucine-valine and leucine biosynthetic enzymes were derepressed 5-to 30-fold above the levels of cells grown with excess leucine (Table 1) . The addition of 100 ,ig of fluoroleucine per ml to cells grown with limiting amounts of leucine reduced the levels of the isoleucine-valine enzymes to nearly that of cells grown with excess leucine. Surprisingly, added fluoroleucine did not repress ,B-isopropylmalate dehydrogenase, the leucine enzyme measured in these experiments.
It appears that the effect of fluoroleucine on repression of the isoleucine-valine enzymes is specific for leucine, since the addition of the analogue to cells grown with either an isoleucine limitation or a valine limitation had no effect on derepression (Table 2) . Furthermore, fluoroleucine had no effect on derepression of the isoleucine-valine enzymes if strain leu 130 ilv 224 was grown with growth-limiting amounts of isoleucine, even though the level of leucine supplied to the auxotroph was quite low (Table 3) .
Numerous leucine-requiring strains of S. typhimurium were examined, and the effect of fluoroleucine on repression was the same; the isoleucinevaline enzymes were repressed while the leucine enzymes remained high (Table 4) .
Effect of fluoroleucine on derepression in a strain prototrophic for the leucine biosynthetic enzymes. It is known that a common system exists in the enteric bacteria for the uptake of the branchedchain amino acids and that these amino acids compete with each other for entry into the cell (18) . It is possible, therefore, that the differential Leucine + fluoroleucine (500 jug/ml). 11.8 4.6 4.4 13 .0 a The minimal medium contained L-isoleucine (50 ,g/ml), L-valine (100 jAg/ml), and L-leucine (50Sg/ml). For derepression, the L-leucine concentration was reduced to 15lAg/ml. b ,3-Isopropylmalate dehydrogenase. The minimal medium contained L-valine (100 ,ug/ml) in addition to the concentrations of L-iSOleucine, L-leucine, and fluoroleucine noted in the table.
b j-Isopropylmalate dehydrogenase.
branched-chain amino acids and, therefore, presumably no competition for entry between the peptide and fluoroleucine.
When strain ilv-A8 was grown with 25 ,ug of glycyl-L-valine per ml and 10 ,ug of L-leucine per ml, the isoleucine-valine and leucine enzymes were derepressed ( Table 5 ). The addition of fluoroleucine repressed the isoleucine-valine enzymes but not the leucine enzymes. When the leucine concentration was raised to 20 ug/ml, the isoleucine-valine enzymes remained high, and the leucine enzymes were low, indicating that the cells were starved for valine. Added fluoroleucine did not repress the isoleucine-valine enzymes, again showing that the effect of the analogue on repression was specific for leucine.
Kinetics of derepression of the isoleucine-valine and leucine enzymes and the effect of fluoroleucine. The above experiments, performed to study the effect of fluoroleucine on repression, were done with cells that had reached the late logarithmic or early stationary phase of growth. It was conceivable, therefore, that fluoroleucine might repress the leucine enzymes early in growth but that this was not apparent because enzymatic analysis was performed at later stages of growth. To test this possibility, strain leu 124 was grown overnight in mininal medium plus excess isoleucine, valine, and leucine. The cells were harvested by centrifugation, washed, and put into minimal medium plus excess isoleucine and valine and limiting leucine, with and without fluoroleucine. Samples were removed during growth, and the levels of the isoleucine-valine and leucine enzymes Fluoroleucine was added at 100 jAg/ml.
b,B-Isopropylmalate dehydrogenase.
were determined. The data in Fig. 1 show that fluoroleucine caused no reduction in derepression of the leucine enzymes at any time during the experiment. In contrast, addition of the analogue prevented derepression of the isoleucine-valine enzymes for the entire experiment. Is the effect of fluoroleucine due to repression or to the synthesis of false protein? Fluoroleucine has been shown, under certain circumstances, to be incorporated into protein in E. coli B (15) . It is possible, therefore, that the lowered levels of the isoleucine-valine enzymes caused by fluoroleucine were due to the formation of functionally altered (false) proteins and not to repression. In an effort to distinguish between these possibilities, the effect of fluoroleucine on the formation of a number of enzymes not directly related to the biosynthesis of the branched-chain amino acids was examined. In this experiment, strain leu 130 was grown in minimal medium with excess isoleucine, valine, leucine, arginine, threonine, and methionine. The cells were harvested during exponential growth and were washed. Part of the cells were used to measure the repressed level of a number of isoleucine-valine, leucine, threonine, and arginine enzymes. The remaining cells were resuspended in medium containing excess isoleucine and valine and limiting leucine. A second flask contained fluoroleucine in addition to the above supplements. The cells were allowed to grow for at least one doubling, and the activity of a variety of enzymes was again determined. Under these conditions, the specific activity of all of the enzymes measured in the cells grown without fluoroleucine increased from 2-to 15-fold (Table 6 ). The addition of fluoroleucine markedly reduced the level of the isoleucine-valine enzymes, but the analogue had no effect on the derepression of the leucine, threonine, and arginine enzymes.
Protection by fluoroleucine of leucme tRNA from periodate oxidation. The extent to which a compound can protect tRNA from oxidation by sodium meta-periodate is good evidence for the ability of the compound to attach to tRNA (1). Total tRNA was extracted from wild-type S. typhimurium grown in minimal medium. The tRNA was subjected to charging conditions by the use of leucine and fluoroleucine by procedures described in Materials and Methods. The tRNA was then treated with periodate, stripped of attached amino acids, and tested for its ability to accept L-leucine-1-14C. The data in Table 7 show that leucine protected approximately 90% of the total leucine tRNA from periodate oxidation. Fluoroleucine also showed good protection, al- A second culture, represented by the closed symbols, was grown with 100 ,ug of fluoroleucine per ml in addition to the supplemented minimal medium. The cultures were started with a large inoculum of washed cells (Klett reading = 30) that were previously grown in minimal medium supplemented with excess isoleucine, valine, and leucine. Samples were removed at the indicated times and the specific activities were determinedfor threonine deaminase, 0; acetohydroxy acid synthetase, O; and,-isopropylmalate dehydrogenase, A.
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REPRESSION OF BRANCHED-CHAIN AMINO ACID ENZYMES though it was almost 25 % less effective than leucine. Increased levels of fluoroleucine did not increase the ability of the analogue to protect leucine tRNA. In experiments not reported here, fluoroleucine was found to be about 25% less effective than leucine in protecting leucine tRNA a Specific activity expressed as micromoles of product per milligram of protein per hour. All of the assays were performed at 37 C except homoserine dehydrogenase and isomeroreductase, which were done at 25 C. The substrate for the isomeroreductase assay was a-acetohydroxybutyrate.
b The cells were grown in minimal medium and 50 Ag of L-arginine, L-threonine, L-methionine, L-leucine, and L-isoleucine per ml, and 100 pg of L-valine per ml. The cells were harvested during exponential growth and washed. Part of the cells were used to measure the repressed levels of the enzymes (leucine excess). The remaining cells were resuspended in medium containing 50 ,g of L-isoleucine per ml, 100 pg of L-valine per ml, and 12 pg of L-leucine per ml (leucine limit). A second flask contained 75 pg of fluoroleucine per ml, in addition to the amounts of isoleucine, valine, and leucine listed above (leucine limit + FL). The cells were grown for one doubling and the enzymatic activities were determined. (15) and S. typhimurium (4) , and this inhibition is reversed specifically by leucine. In addition, trifluoroleucine acts as a false-feedback inhibitor of the initial enzyme in leucine biosynthesis (5), and the analogue has been shown to be incorporated into protein, in E. coli, in place of leucine (15) .
The data presented here indicate that fluoroleucine can replace leucine for repression of the isoleucine-valine biosynthetic enzymes in S. typhimurium. The effect of the analogue on repression was specific for leucine, since fluoroleucine had no effect on derepression of the isoleucine-valine enzymes in auxotrophs grown with an isoleucine or valine limitation. Furthermore, the prevention of derepression by fluoroleucine appeared to be due to repression and not to the formation of functionally altered (false) proteins, since the analogue had no effect on the synthesis of a number of enzymes from unrelated pathways.
Most surprising was the observation that fluoroleucine had no effect on repression of the leucine biosynthetic enzymes in the seven leucine auxotrophs of S. typhimurium that were examined. It has recently been shown that leucine must be activated by leucyl-tRNA synthetase before it is able to participate in repression of the isoleucinevaline and leucine enzymes (Alexander, Freundlich, and Calvo, in preparation). Furthermore, it was found in the present studies that fluoroleucine can attach to leucine tRNA. Therefore, the inability of the analogue to repress the leucine enzymes under conditions where it repressed the isoleucine-valine enzymes was unexpected. This difference in repression by fluoroleucine may have one of several explanations. (i) Fluoroleucine may saturate the isoleucine-valine repression system more rapidly than the leucine system. This seems unlikely because high concentrations of the analogue did not act to repress the leucine enzymes. In fact, increased amounts of fluoroleucine caused an even greater derepression in the leucine enzyme that was measured. (ii) The binding of fluoroleucine to a component involved in repression of the leucine enzymes may not allow the proper conformation for this component to be active. Conversely, this change in conformation does not prevent the functioning of the isoleucinevaline repression system. (iii) A different leucine tRNA species may be required for repression of each of these systems. Thus, fluoroleucine may 106 FREUNDLICH attach to the leucine tRNA species necessary for repression of the isoleucine-valine enzymes, but the analogue may be unable to bind to the leucine tRNA species involved in repression of the leucine enzymes. This explanation is given some support by the observation that maximal protection by fluoroleucine of periodate oxidation of leucine tRNA was only 70%. If, in fact, fluoroleucine can attach to some but not all of the leucine tRNA species, it might be expected that the analogue would have ambivalent effects on other metabolic processes in which leucine tRNA is involved. The following paper (17) shows that fluoroleucine allows protein synthesis during leucine starvation but that RNA synthesis is completely blocked under these conditions.
